日期 影响因子
日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:
–

Safety of Secukinumab from 1 Million Patient-Years of Exposure: Experience from Post-Marketing Setting and Clinical Trials

塞库奇尤单抗在100万患者年暴露中的安全性：来自上市后研究和临床试验的经验

期刊:Dermatology and Therapy
影响因子:4.2
doi:10.1007/s13555-024-01122-2
Sun, Rui; Bustamante, Mercedes; Gurusamy, Venkatesh Kumar; Lebwohl, Mark; Gottlieb, Alice B; Mease, Philip J; Deodhar, Atul; Bao, Weibin; Mendelson, Meryl; Porter, Brian; Chand, Deepa; Dong, Victor
发表日期：2024
文献求助 收藏

Detection, Monitoring, and Mitigation of Drug-Induced Nephrotoxicity: A Pragmatic Approach

药物性肾毒性的检测、监测和缓解：一种务实的方法

期刊:
影响因子:
doi:10.1007/s43441-023-00599-x
Antognini, Nicola; Portman, Ronald; Dong, Victor; Webb, Nicholas J; Chand, Deepa H
毒理研究
发表日期：2024
文献求助 收藏

Liver injury in cynomolgus monkeys following intravenous and intrathecal scAAV9 gene therapy delivery.

食蟹猴经静脉和鞘内注射 scAAV9 基因治疗后出现肝损伤

期刊:Molecular Therapy
影响因子:12
doi:10.1016/j.ymthe.2023.07.020
Hudry Eloise, Aihara Fumiaki, Meseck Emily, Mansfield Keith, McElroy Cameron, Chand Deepa, Tukov Francis Fonyuy, Penraat Kelley
毒理研究
发表日期：2023
文献求助 收藏

Neurofilament light chain and dorsal root ganglia injury after adeno-associated virus 9 gene therapy in nonhuman primates

非人灵长类动物腺相关病毒9基因治疗后神经丝轻链和背根神经节损伤

期刊:Molecular Therapy-Methods & Clinical Development
影响因子:4.7
doi:10.1016/j.omtm.2022.12.012
Johnson, Eric W; Sutherland, Jeffrey J; Meseck, Emily; McElroy, Cameron; Chand, Deepa H; Tukov, Francis Fonyuy; Hudry, Eloise; Penraat, Kelley
微生物学
基因治疗
发表日期：2023
文献求助 收藏

Review of cardiac safety in onasemnogene abeparvovec gene replacement therapy: translation from preclinical to clinical findings

对onasemnogene abeparvovec基因替代疗法的心脏安全性进行评估：从临床前研究到临床研究的转化

期刊:Gene Therapy
影响因子:4.5
doi:10.1038/s41434-023-00401-5
Chand, Deepa H; Sun, Rui; Diab, Karim A; Kenny, Damien; Tukov, Francis Fonyuy
发表日期：2023
文献求助 收藏

Single-Dose Intrathecal Dorsal Root Ganglia Toxicity of Onasemnogene Abeparvovec in Cynomolgus Monkeys

单剂量鞘内注射Onasemnogene Abeparvovec对食蟹猴背根神经节的毒性

期刊:Human Gene Therapy
影响因子:4
doi:10.1089/hum.2021.255
Tukov, Francis Fonyuy; Mansfield, Keith; Milton, Mark; Meseck, Emily; Penraat, Kelley; Chand, Deepa; Hartmann, Andreas
Monkey
发表日期：2022
文献求助 收藏

Correction to: Clinical Trial and Postmarketing Safety of Onasemnogene Abeparvovec Therapy

更正：Onasemnogene Abeparvovec疗法的临床试验和上市后安全性

期刊:Drug Safety
影响因子:3.8
doi:10.1007/s40264-021-01130-7
Day, John W; Mendell, Jerry R; Mercuri, Eugenio; Finkel, Richard S; Strauss, Kevin A; Kleyn, Aaron; Tauscher-Wisniewski, Sitra; Tukov, Francis Fonyuy; Reyna, Sandra P; Chand, Deepa H
发表日期：2022
文献求助 收藏

Clinical Trial and Postmarketing Safety of Onasemnogene Abeparvovec Therapy

Onasemnogene Abeparvovec疗法的临床试验和上市后安全性

期刊:Drug Safety
影响因子:3.8
doi:10.1007/s40264-021-01107-6
Day, John W; Mendell, Jerry R; Mercuri, Eugenio; Finkel, Richard S; Strauss, Kevin A; Kleyn, Aaron; Tauscher-Wisniewski, Sitra; Tukov, Francis Fonyuy; Reyna, Sandra P; Chand, Deepa H
发表日期：2021
文献求助 收藏

Pattern of Laboratory Parameters and Management of Secondary Hyperparathyroidism in Countries of Europe, Asia, the Middle East, and North America

欧洲、亚洲、中东和北美国家继发性甲状旁腺功能亢进症的实验室参数模式及治疗

期刊:Advances in Therapy
影响因子:4
doi:10.1007/s12325-020-01359-1
Cozzolino, Mario; Shilov, Eugeniy; Li, Zuo; Fukagawa, Masafumi; Al-Ghamdi, Saeed M G; Pisoni, Ronald; Bieber, Brian; Vallabh, Bhadrish; Chand, Deepa H
发表日期：2020
文献求助 收藏

Recommended Clinical Trial End Points for Dialysis Catheters

透析导管临床试验推荐终点

期刊:Clinical Journal of the American Society of Nephrology
影响因子:7.1
doi:10.2215/CJN.12011116
Allon, Michael; Brouwer-Maier, Deborah J; Abreo, Kenneth; Baskin, Kevin M; Bregel, Kay; Chand, Deepa H; Easom, Andrea M; Mermel, Leonard; Mokrzycki, Michele H; Patel, Priti R; Roy-Chaudhury, Prabir; Shenoy, Surendra; Valentini, Rudolph P; Wasse, Haimanot
发表日期：2018
文献求助 收藏